Letter-Gambee

by | Apr 1, 2011

Suspension Not Due to Patient Complaints

In response to the [Letter from the Publisher, January 2011], I would like to make a statement.  

The Oregon Medical Board (OMB) complaints regarding my medical practice have nothing to do with harming a patient, or even complaints from patients I have treated. They appear to center on the 1995 amendment to the Medical Practice Act, ORS 677.190(A). This amendment allows the alternative treatment of medical conditions with methods not currently considered “mainstream,” or “conventional.” These treatments are considered to be as safe as the traditional treatments by the doctors using them and the patients receiving them.

The OMB wants to decide what is the safest of the choices, or what constitutes an alternative medical practice. This desire of the OMB was rejected when it was proposed in 1995 during hearings on this bill. The legislature clearly asserted that it was the doctors that were to make that decision and overrode Gov. Kitzhaber’s veto almost unanimously.

The therapeutic choices in these cases are backed by current, peer-reveiwed, medical literature. For example, the decision to use testosterone in a patient with prostate cancer to improve quality of life is not some crazy idea. A review article of this topic can be found in Urology Clinics of North America 34 (2007)555-563, or in Medical Clinics of North America, Supplement 1, 2006 pg 23, or The New England Journal of Medicine Jan 29, 2004, pg 482, or J of Steroid Biochemistry & Molecular Biology 102(2006) 261 – 266, etc., etc. This and much more was presented to the OMB and ignored.

The fallacy of the TSH test in determining the need for thyroid hormone replacement was another bone of contention with the OMB, despite the presentation of an alternative point of view that considers the safety of and many benefits of adequate thyroid hormone replacement.

One set of guidelines which the OMB insist that I follow was issued by the Endocrine Society regarding the use of testosterone. By the author’s own admission, as stated in the article, a review of the evidence used as the basis for these guidelines, is “very poor quality” evidence 75% of the time; 25% of the guidelines were based on “poor” quality evidence; and none were based on “moderate” or “high” quality evidence; so much for “evidence-based” medicine. See J of Clinical Endocrinology & Metabolism, June 2010, 95(6):2536-2559 see esp “Methods of Development of Evidence-based Clinical Practice Guidelines” page 2539.

Advertisement

The patient charts that were the basis of the complaint and emergency suspension were reviewed by three and sometimes four other Oregon physicians. In each of these cases the reviewing doctor felt that there was no violation of the Medical Practice Act or violation of the Stipulated Orders the OMB had placed on my practice.

Peer-review is a basic tenet of the practice of medicine. Typical of the OMB, none of the “experts” testifying against my practices had heard of the amendments to the Medical Practice Statute, made in 1995, and were unaware of legitimate alternative practices.

My “emergency suspension” was based on the fact the the OMB alleged that I had failed to do a prostate exam on two patients when the chart notes on both of these patients clearly demonstrated that the exam had been done. The reviewing doctors and one of the OMB consultants at the hearing concurred with our opinion that no violation of the OMB order had been committed. Despite this fact, the OMB issued an emergency suspension, and has refused to consider lifting the suspension at this writing, four months later.

Generously, after suspending my license, the OMB reminds me that I have the right to hire an attorney to defend myself. Were it not for the generosity of my attorney William Wheatley, a volunteer staff, and donations from like-minded patients, I would definitely by out on the streets again.

There is nothing to hide in these cases. I have offered to sign a release of information on any of the records, or complaints the OMB has in my file. The OMB does not allege that I have harmed a patient, it is always that I might, even after practicing medicine in Oregon since 1979.

Go figure!

John E. Gambee, MD

www.drgambee.com

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

The GMO-to-Cancer Pathway

By Michelle Perro, MD – Early-onset colorectal cancer, generally defined as colorectal cancer diagnosed before age 50, has been rising for decades. The phenomenon is particularly disturbing because many cases occur in people without an obvious hereditary cancer syndrome.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This